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Abstract
Human Respiratory Syncytial Virus (HRSV) is a leading cause of bronchopneumonia in
infants and the elderly. To date, knowledge of viral and host protein interactions within
HRSV is limited and are critical areas of research. Here, we show that HRSV Matrix (M) protein interacts with the cellular adaptor protein complex 3 specifically via its medium subunit
(AP-3Mu3A). This novel protein-protein interaction was first detected via yeast-two hybrid
screen and was further confirmed in a mammalian system by immunofluorescence colocalization and co-immunoprecipitation. This novel interaction is further substantiated by the
presence of a known tyrosine-based adaptor protein MU subunit sorting signal sequence,
YXXФ: where Ф is a bulky hydrophobic residue, which is conserved across the related RSV
M proteins. Analysis of point-mutated HRSV M derivatives indicated that AP-3Mu3A- mediated trafficking is contingent on the presence of the tyrosine residue within the YXXL sorting
sequence at amino acids 197–200 of the M protein. AP-3Mu3A is up regulated at 24 hours
post-infection in infected cells versus mock-infected HEp2 cells. Together, our data suggests that the AP-3 complex plays a critical role in the trafficking of HRSV proteins specifically matrix in epithelial cells. The results of this study add new insights and targets that may
lead to the development of potential antivirals and attenuating mutations suitable for candidate vaccines in the future.

Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.

Introduction

Funding: This research was funded in part by
Medical Research Foundation, Oregon Health and
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Human Respiratory Syncytial Virus (HRSV) is the leading cause of acute lower respiratory
tract infection (ALRI) in infants and it is estimated that globally 66,000–199,000 children
younger than 5 years died from HRSV-associated ALRI in 2005 [1]. HRSV belongs to the
Paramyxoviridae family and is an enveloped, negative sense, single-stranded RNA virus encoding 11 proteins [2]. HRSV infection occurs preferentially through the apical surface of the
most superficial layer of the polarized epithelium of the respiratory tract [3, 4]. Viral assembly
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and budding occur late in the viral life cycle at the apical surface and are coordinated by the
interaction of the HRSV Matrix (M) protein with the cytoplasmic tails of viral proteins [2].
The envelope glycoproteins are translocated to lipid rafts at the apical membrane through an
interaction with M along with the preformed nucleocapsids, facilitating final assembly and
budding [2, 5].
The HRSV M protein exhibits a unique characteristic in that it localizes to the nucleus early
in infection and exports late in infection. Thus, it has been proposed that the M protein may
function as a type of ‘biological clock’ for the virus by entering the nucleus early in infection to
inhibit host cell transcription, thereby focusing the efforts of the infected cells machinery on
viral replication, then exiting late in infection from the nucleus to terminate viral replication in
preparation for virus assembly, only once sufficient viral protein has accumulated in cells [2, 6,
7, 8].
There exists four heterotetrameric adaptor protein complexes, AP-1, AP-2, AP-3, and AP4, which mediate the sorting of proteins to specific membrane components of the cell [9]. AP
complexes are made up of two large subunits, a medium subunit, and a small subunit (delta
and beta3, mu3 and sigma3 respective to the AP-3 complex). The AP-3 complex also contains
two isoforms in its mu subunit, with mu3A expressed ubiquitously and mu3B expressed only
in neurons and neuroendocrine cells [10]. The AP-3 complex specifically forms part of the
cytoplasmic coat of vesicles that mediate transport of trans-membrane proteins between the
trans-Golgi, endosomes and lysosomes. The selection of cargo by the AP complexes requires
the recognition of specific motifs found in the cytoplasmic tail of transmembrane cargo [11].
These sorting signals include tyrosine-based motifs (YXXФ: where X can be polar residues and
Ф is a bulky hydrophobic residue) and di-leucine/acidic residue-containing motifs [9, 10, 12,
13].
Here, we demonstrate that the AP-3 complex binds HRSV M via its mu-subunit and is further stabilized by an interaction with AP-3delta. In addition, point mutated derivatives of
HRSV M in its conserved YXXL (Y, tyrosine; L, leucine) sorting motif at amino acids 197–200
(197-YXXL-200) impair the ability of HRSV M to traffic to proper sites of viral assembly late
in infection.

Materials and methods
Screening of HeLa cDNA library with HRSV M using Matchmaker yeast
two-hybrid system
The yeast two-hybrid screen was performed using Clontech’s Matchmaker two-hybrid system
with a pre-transformed HeLa cDNA library as prey and the HRSV Matrix protein as bait. The
RSV M/pAS2-1 plasmid was transformed into yeast strain PJ69-2A, and the transformed PJ692A cells were mated with a pre-transformed HeLa cell cDNA library (Clontech) in yeast strain
Y187. Several novel interactions were detected using dropout medium lacking leucine, tryptophan, and histidine in addition to beta-galactosidase assays. Plasmids from positive interactions were isolated using the E.Z.N.A yeast plasmid kit (Omega) then sequenced at the Center
for Genome Research and Biocomputing (CGRB) core facility at Oregon State University.
Gene identity was determined by performing a BLAST search of the insert sequence.

Yeast two-hybrid method to confirm specific interaction
The specificity of interaction of HRSV M and Adaptor protein 3 was further confirmed in
yeast two-hybrid. Adaptor protein 1 and empty plasmids with out the cDNA fusions were
used as a negative control. Fusions with the GAL4 DNA- binding domain (GAL4DB) were
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constructed in pGBT9, and those with the GAL4 activation domain (GAL4AD) were constructed in pGAD424 [14]. The cDNA fusions were performed by ligation of cDNA that had
been amplified with the polymerase chain reaction (PCR) [15] using oligonucleotide linkers to
allow the in-frame insertion into the yeast expression vectors. Sequencing of inserts was performed to make sure that the inserts have no mutations and are in frame with the GAL4DB/
AD at Oregon State University’s Center for Genome Research and Biocomputing (CGRB)
core facility.

beta-Galactosidase assay
beta-Galactosidase activity in each of the transformants was measured. The colony beta-Galactosidase color assay and quantitative beta-Galactosidase assay were performed as described by
Vojtek et al. [16]. Activity is expressed in standard units [1] multiplied by 1,000. All results
were reproducible in at least two independent assays.

Antibodies
The primary specific antibodies that were used are the following monoclonal mouse antiMatrix (a kind gift from Erling Norrby and Mariethe Ehnlund, Karolinska Institute, Sweden),
polyclonal goat anti-AP-3Mu3A (Santa Cruz Biotechnology, Cat# sc-6425), monoclonal
mouse anti-AP-3delta (a kind gift from Andrew Peden, University of Cambridge), polyclonal
goat anti-HRSV (Chemicon, Cat# AB1128), polyclonal goat anti-H1N1 (Thermo Fisher Scientific, Cat# PA1-7221), Mouse mAb anti-GAPDH (Calbiochem, Cat# CB1001) 1:4000 and
monoclonal mouse anti-HIV-1 p24 Gag (NIH AIDS Research & Reference Reagent Program).
The secondary specific antibodies that were used are the following: donkey anti-mouse
Alexa-Fluor 546 (Invitrogen, cat# A10036), rabbit anti-goat Alexa-Fluor 488 (Thermo Fisher
Scientific, Cat# A-11078), donkey anti-goat IR Dye 800 (Rockland, Cat# 605-745-125) and
donkey anti-mouse IR Dye 700 (Rockland, Cat# 610-744-002).

Cell culture and transfection
HEp-2 (American Type Culture Collection, ATCC) cells grown at 37˚C and 5% CO2 in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 100U penicillin, 100μg/mL
streptomycin, 0.25μg/mL amphotericin B and 10% fetal bovine serum (P/S/A/FBS) were transfected with indicated constructs using Fugene HD (Roche) according to plasmid optimization
and manufacturer’s protocol.

Virus and infection
The laboratory strain VR-1540™ HRSV A2 (American Type Culture Collection, ATCC) was
grown, assayed and stored as previously described [15]. HEp2 cells were plated day before
infection at desired confluency, HRSV was adsorbed for one hour with 10 minute interval
shaking at indicated MOI at 37˚C and 5% CO2 in DMEM + FBS. Virus was removed and
replaced with DMEM + P/S/A/FBS. Virus stocks were stored at −80˚C until used. Stock virus
titers were determined by plaque assay.

Plaque assay
HRSV plaque assays were performed in HEp-2 cells seeded into 24-well plates and grown until
confluent. Serial tenfold dilution of samples was made and plaque assays performed as previously described [15]. Virus titer was determined by the highest dilution in which duplicate
wells contained at least 5 plaques.
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Plasmid constructs
The construct used to express the HRSV M protein in mammalian cells was a codon optimized
M protein (Opt.M) (a kind gift from James E. Crowe, Jr., Vanderbilt University School of
Medicine). The Opt.M construct and point-mutated derivatives thereof were subsequently
placed in-frame into pcDNA 3.1(-) (Invitrogen) and pEGFP-C1 (Clontech) vectors using
EcoRI and BamHI restriction sites. These plasmid constructs were used for co-immunoprecipitation and colocalization studies respectively.
To generate the Y197A point-mutated Opt.M pcDNA 3.1(-) construct a specific forward
primer (TCATCCCTGCCTCAGGATTACTATTAGTCATCACA [boldface type indicates Y197A
point-mutation]) and a reverse primer complementary to Opt.M with a BamHI site
(GAGCTCGGATCCTCAGTCCTC)[the underlined sequence indicates the BamHI restriction
site] were used to introduce the Y197A point–mutation and amplify the desired regions of
Opt.M (194–256 amino acids [aa]) with the Opt.M pcDNA 3.1(-) construct used as template.
A specific reverse primer (ATCCTGAGGCAGGGATGATTTTTGCATTTGTGATA [boldface type
indicates Y197A point-mutation]) and a Opt.M specific forward primer with a EcoRI site
(TCTGCAGAATTCGCCACCATGGAGACC [the underlined sequence indicates the EcoRI restriction site]) were used to introduce the Y197A point-mutation and amplify the desired regions
of Opt.M (1–199) aa). These initial overlapping PCR fragments were made using Pfx polymerase kit (Invitrogen). Aliquots from each of the above reactions were combined and used as
template for the PCR ligation step to make the full length Y197A Opt.M DNA construct using
PCR Supermix with Taq (Invitrogen).
The protocol described above was also used to generate the L200A Opt.M overlapping fragments and subsequent full length DNA construct with the following changes in the specific
primers used to introduce the desired L200A point-mutation: specific forward primer
(TACAGCGGCGCCCTGCTGGTGATC [boldface type indicates L200A point-mutation]) to introduce the L200A point-mutation and amplify the desired regions of Opt.M (197–256) aa and
specific reverse primer (CACCAGCAGGGCGCCGCTGTAAGG [boldface type indicates L200A
point-mutation]) to introduce the L200A point-mutation and amplify the desired regions of
Opt.M (1–203) aa. Full-length constructs were placed into appropriate vector, screened and
sequenced to confirm proper insertion at Oregon State University’s Center for Genome
Research and Biocomputing (CGRB) core facility.

Colocalization and immunofluorescence
Subconfluent (80%) HEp2 cell monolayers grown on glass coverslips were infected with HRSV
A2, mock-infected or transfected with various plasmid cDNAs and cultured for the indicated
times after infection or transfection. Cells were washed with ice-cold PBS and fixed with 4%
paraformaldehyde for 10 min at room temperature, followed by the permeabilization of membranes with 0.2% Triton X-100 for 5 min. Fixed cells were washed thoroughly in PBS and incubated for one hour in bovine serum albumin (BSA)-PBS (1% BSA/PBS) as a preliminary
blocking step. Subsequently, fixed cells were incubated for one hour in primary, specific antibody diluted in 1% BSA/PBS blocking buffer. Fixed cells were extensively washed with a
Tween-20 containing wash buffer and bound antibodies were detected with species-specific
fluorochrome-conjugated secondary antibodies via one-hour incubation in dark. Coverslips
were mounted in fluorescent mounting medium containing DAPI (Vectashield, Vector Laboratories) and analyzed by confocal laser scanning microscopy (CLSM). Pinhole diameter was
1 μm for all analyses. Multi-track configuration was performed on CGRB Zeiss 540 Meta Confocal Microscope. Images of more than 20 cells were analyzed for each sample.
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Co-immunoprecipitation
Subconfluent (90%) HEp2 cell monolayers grown in a 75cm2 flask were either infected or
mock-infected with HRSV A2 at an MOI of 5. Post 24 hours infection, 1 ml ice cold MPER
(Pierce) buffer was added to cell monolayer and incubated for 10 minutes on a rocker. Cells
were scraped and lysate was vortexed briefly in a microcentrifuge tube. Cellular debris was pelleted by centrifugation at 10,000xg for 10 minutes at 4˚C. Supernatant was transferred to new
tube together with 1.0 μg of specific antibody and incubated at 4˚C for 1 hour. 20μl of resuspended volume of Protein A/G PLUS-Agarose (Santa Cruz Biotechnologies) was added and
then further incubated at 4˚C on rotating device overnight. Immunoprecipitates were collected
by centrifugation at 2,500 rpm for 5 minutes at 4˚C. Supernatant was then discarded and pellet
was washed 4 times with 1.0 ml PBS, each time repeating centrifugation step above. After final
wash, supernatant was aspirated and discarded and pellet was resuspended in 40μl of 1x LDS
electrophoresis sample buffer (Invitrogen). Samples were boiled for 2–3 minutes (70˚C) and
20μl aliquots were analyzed by SDS-PAGE Western Blot. Blots were transferred to nitrocellulose, blocked for one hour in (Odyssey) blocking buffer then probed with either goat-antiHRSV polyclonal antibody or monoclonal mouse anti-HRSV M. Blots were washed four times
for 5 minutes after each incubation with antibody in PBS-H2O with 0.2% Tween 20 washing
solution, and then were probed with IR labeled specific secondary antibodies, washed, and
analyzed on an Odyssey Infrared Imaging Center (Licor).

Western blot and fluorescence intensity analysis
6-well plates were seeded with approximately 1.0 x 106 HEp2 cells, mock-infected or infected
next day at an MOI of 5, then proteins were extracted using MPER (Pierce) with Protease
Arrest and scraping from triplicate wells at respective times post-infection. Cell lysates plus
NuPAGE Reducing Agent (Invitrogen) were heated at 70˚C for 10 minutes and equal amounts
of protein were resolved on 4–12% Bis-Tris gels (Invitrogen) in triplicate, followed by transfer
to nitrocellulose. Blots were blocked in Rockland IR blocking buffer overnight and then
probed with Goat anti-Ap3Mu3A (1:200), Mouse anti-RSV Matrix (1:1000), Rabbit anti-delta
adaptin (SA4) (1:1000), Rabbit anti-GAPDH (1:10000) for one hour. Washed extensively in
Tween-20 containing wash buffer, then blotted with species-specific IR labeled antibodies:
Donkey anti-Goat IR 800 (1:25000), Donkey anti-Rabbit IR 800 (1:25000), Donkey anti-Rabbit
IR 700 (1:5000), Donkey anti-Mouse IR 700 (1:5000), Donkey anti-Mouse IR 800 (1:20000) for
an hour and then washed extensively. Blots were imaged on Licor IR Imager, fluorescent
intensity analysis was performed using Licor imaging program and subsequent data analysis
was performed by comparing infected versus uninfected triplicate averages of the integral
intensity ratio between GAPDH loading control and AP3 integral intensities via unpaired two
tail t-test.

Statistics
All statistics were performed using GraphPad Prism version 4.00 for Windows (GraphPad
Software, San Diego, CA) by one-way ANOVA and either Bonferroni or Dunnett’ post-tests,
or two-way ANOVA with Bonferroni post-test.

Results
HRSV M binds to the MU subunit of the AP-3 complex
We performed a yeast-two hybrid screen of a HeLa cDNA library using full-length HRSV
Matrix as bait to identify Matrix binding partners. Our screen identified six candidate Matrix
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binding partners using dropout medium lacking leucine, tryptophan, and histidine in addition
to beta-galactosidase assays. We chose one of these candidates for further evaluation, the AP3Mu3A protein, based on its significant role in interactions with the matrix protein of other
viruses. One other candidate, ubiquitin C was shown by our lab to be important in HRSV
pathogenesis [15].
To test the specificity of interaction of HRSV M and AP-3Mu3A, we fused the GAL4DB
with HRSV M and the GAL4AD with AP-3Mu3A. The GAL4AD with AP-1 and empty plasmids were used as negative controls. These plasmids were then co-expressed in S. cerevisiae
Y153, and the intensity of the interaction was measured either in the colony color assay or as
beta-Galactosidase activity (Table 1). Interaction between HRSV M and the AP-3Mu3A was
the strongest, with a blue color being detectable within 2 h by colony filter color assay. Controls in which either the HRSV M or the AP-3Mu3A was omitted showed no blue color for up
to 12 h (Table 1). Likewise, there was no interaction when HRSV M was paired with constructs
containing the AP-1. Interaction between HRSV M and AP-3Mu3A was orientation independent as switching between GAL4DB and GAL4AD did not significantly alter beta-Galactosidase color assay units. The results show that the interaction between HRSV M and AP-3Mu3A
was specific in yeast two-hybrid system.

HRSV M protein colocalizes with AP-3Mu3A protein in HRSV infected
cells
To investigate the association of the M protein with AP-3 in HRSV-infected cells, fixed HEp2
cells were probed with HRSVM and AP-3Mu3A specific antibodies and examined by confocal
laser scanning microscopy (CLSM). At 12 hours post infection (p.i.), the M protein is localized
at juxtanuclear regions of the cytoplasm with a small contingency still residing within the
nucleus (Fig 1A). At 24 hours p.i., M is seen localizing to the cytoplasmic side of the membrane
at sites of viral assembly and budding as well as in distinct cytoplasmic inclusions containing
the viral nucleocapsid proteins (L, N, P, M2-1) that are sites of viral transcription [14] (Fig 1B).
This expression pattern for M is consistent with previously published data [2, 7, 14]. The AP3Mu3A protein complex localizes to the juxtanuclear region extending out through the cytoplasm to the cell margin at 12 hours post HRSV infection (Fig 1A). While at 24 hours, AP3Mu3A is seen extending out through the cytoplasm to the cell margin as well; it is also localized within the cytoplasmic inclusions formed by the HRSV nucleocapsid proteins (Fig 1B).
The cytoplasmic and juxtanuclear fluorescent pattern for the AP-3 adaptor complex is consistent with previously published data [17, 18, 19, 20, 21]. Colocalization of M with the AP3Mu3A protein can be most distinctly observed in the juxtanuclear region at 12 hours p.i and
in cytoplasmic inclusions at 24 hours. In both time points colocalization can be observed at
various sites in the cytoplasm as well as at the cell margin (Fig 1A and 1B). The colocalization
observed at 12 and 24 hours post HRSV infection suggests a direct interaction between the
HRSV M and AP-3Mu3A and may represent a pathway for the association of the M protein
and viral nucleocapsids late in HRSV infection. In addition, mock-infected HEp2 cells showed
no bleed-through or background fluorescence and further validated the specificity of both AP3Mu3A and M antibodies (Fig 1C).

AP-3Mu3A and AP-3delta co-immunoprecipitate with the HRSV M
protein
To further confirm the interaction between AP-3Mu3A and HRSV M and to determine if auxiliary stabilization existed from a corresponding subunit of the AP-3 hemicomplex, a coimmunoprecipitation analysis was performed. Immunoprecipitation of AP-3Mu3A and AP-
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Table 1. Interaction of adaptor proteins with the RSV matrix protein in a yeast two-hybrid system.
GAL4DB

GAL4AD

Colony color

beta-Galactosidase activity, units

Empty

Empty

---

1-2

Empty

Adaptor 3

---

1-2

HRSV M

Empty

---

1-2

HRSV M

Adaptor 3

+++

458

HRSV M

Adaptor 1

---

5-6

Adaptor 3

HRSV M

+++

420

The intensity of the interaction was measured either in the colony color assay or as beta-galactosidase activity. ‘‘Empty” indicates no insert in the vector. (A)
Colony color assay. The colonies were grown on a plate containing appropriate medium, transferred onto a nitrocellulose filter, and lysed by rapid freezing in
liquid nitrogen. The filters then were placed on a plate containing Z-buffer and 5-bromo-4-chloro-3-indolyl beta-D-galactoside (X-Gal) to analyze the enzyme
activity. When HRSV M and Adaptor 3 were coexpressed in yeast, colonies showed a blue color within 2 h, whereas controls in which either the HRSV M or
the Adaptor 3 were omitted showed no blue color for up to 12 h. (B) Quantitation of the interaction between HRSV M and the Adaptor 3 proteins. The colony
color assay is graded as white (- - -) or dark blue (+++). beta-Galactosidase activity was quantitated and expressed in standard units multiplied by 1,000. The
results were reproducible in at least two independent assays.
https://doi.org/10.1371/journal.pone.0184629.t001

Fig 1. The M protein is seen associating with the AP-3Mu3A protein in distinct juxtanuclear cytoplasmic
regions at 12 hours p.i. and in cytoplasmic inclusions at 24 hours p.i. HRSV-infected and mock-infected
HEp2 cells were fixed 12 h and 24h after infection and were double stained with various antibody combinations,
followed by CLSM analysis. The antibodies used are as indicated: goat anti-AP-3Mu3A (1:50), mouse antiMatrix (1:100), rabbit anti-goat Alexa-Fluor 488 (1:200), donkey anti-mouse Alexa-Fluor 546 (1:200). Primary
antibodies were incubated for 60 minutes; cells were then washed with Tween 20 wash solution and then
subsequently incubated for 60 minutes with secondary antibodies. DAPI, is the 405 nm output corresponding to
a blue color in the image above; AP-3Mu3A, is the 488nm output corresponding to the green color in the image
above; HRSV Matrix, is the 546nm output corresponding to the red color in the image above; Merge, is the
computer-generated merged image of all three outputs, with yellow coloration indicating colocalization. The
results were reproducible in at least three independent assays. Scale bar is 10μm.
https://doi.org/10.1371/journal.pone.0184629.g001
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3delta using an anti-AP-3Mu3A polyclonal and an anti-AP-3delta monoclonal antibody
respectively, was carried out using cell lysates from both HRSV and mock infected HEp2 cells
at 24 hours p.i. Through immunoblotting for HRSV proteins, both an anti-HRSV polyclonal
and an anti-Matrix monoclonal antibody detected the 28kD Matrix protein in HRSV infected
lanes alone (Fig 2A and 2B; S1 Fig). This further substantiates a protein-protein interaction
between the AP-3Mu3A subunit and the HRSVM protein as well as indicates that at least the
AP-3delta subunit of the AP-3 hemicomplex is involved in further stabilization of this interaction. To insure the specificity of both AP-3 antibodies in pulling down the M protein under
these co-immunoprecipitation conditions and protocol, anti-H1N1 polyclonal and anti-HIV
p24-GAG monoclonal antibodies were used as isotype controls to validate the results of AP3Mu3A and AP-3delta experiments respectively. These control experiments resulted in no
detection of HRSV M or other viral proteins suggesting that the precipitation of the HRSVM
protein via the AP-3 complex is a specific interaction (Fig 2A and 2B; S1 Fig).

Conservation of 197-YXXL-200 motif in related-RSV strains
To determine if an interaction between AP-3Mu3A and M is critical for RSV and to determine
whether the motif is conserved among RSV strains that may play a role in maintaining pathogenesis and/or function, a sequence alignment was performed comparing the various RSVrelated Matrix proteins as well as human metapneumovirus A (HMPV A). As shown in Fig 3,
a clearly defined tyrosine based YXXL homologous region is retained at amino acids 197–200.
In addition, there exists a subsequent YXXL region at amino acids 20–23 of the HRSV M protein, but this motif was not conserved across the same RSV-related strains and was thus not
explored further in this study (data not shown). The presence of this highly conserved homologous region provides further evidence that an interaction with the AP-3Mu3A subunit is critical for RSV pathogenesis across various RSV-related strains.

197-YXXL-200 binding motif is critical for interaction of M protein with
AP-3Mu3A
To confirm that the conserved 197-YXXL-200 sequence motif is essential for the proper interaction between M and AP3Mu3A, point mutations of the tyrosine and leucine residues of the
197-YXXL-200 sorting signal motif to alanine were designed, Y197A and L200A respectively
(Fig 4A). We evaluated the phenotypic difference between the wt, Y197A and L200A Opt.M
constructs via cloning into a fluorescence expression vector, pEGFP-C1. One-half of the cell
culture wells from each transfected cell group (wt, Y197A and L200A) were infected with
HRSV and were stained with primary polyclonal goat anti-HRSV antibodies (Chemicon) and
secondary donkey anti-goat IR Dye 800 antibodies (Rockland). At 24 hours post-transfection,
CLSM analysis showed the wt Opt. M construct localizing throughout the cytoplasm in a
punctuate pattern, especially absent from the nucleus (Fig 4B). HRSV colocalizes with the wt
M as indicated by the image with yellow coloration (Fig 4B). This expression pattern is consistent with the localization of M late in RSV infection. In comparison, the Y-197-A and L200A
Opt.M constructs were seen localized exclusively in nuclear and juxtanuclear regions especially
absent in cytoplasmic regions extending to the cell margin (Fig 4C). The HRSV may be seen
budding but appear stuck and unable to get released from the cell membrane. The localization
of the Y197A and L200A Opt.M mutant was similar to the expression pattern seen in HRSV
infected cells 12 hours p.i. This observation suggests that because of the mutation of these vital
tyrosine and leucine residues, the ability of AP-3 to direct M properly away from the juxtanuclear region toward cytoplamsic inclusions and/or sites of viral assembly late in infection was
halted or impaired.
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Fig 2. The HRSV M protein co-immunoprecipitates with the AP-3Mu3A and AP-3delta complex during
HRSV infection. HEp2 cells at approximately 90% confluency were either infected at an MOI of 5 or mock
infected for 24 hours, cells were scraped or proteins were subsequently extracted using MPER. Cell lysates
were incubated for 6 hours with 1 μg of either polyclonal goat anti-AP-3Mu3A or monoclonal mouse anti-AP3delta along with a antibody specific isotype control, polyclonal goat-anti H1N1or monoclonal mouse anti-HIV1 p24 Gag at 4˚C on a rotating device. 20μl Protein A/G agarose beads were added to lysate plus
corresponding antibody and incubated overnight. Immunoprecipate complex was pelleted and washed with
PBS and then ran out on a SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was
blocked and then probed with either monoclonal mouse anti-Matrix or polyclonal goat-anti HRSV primary
antibody as described previously for one hour. Membranes were then washed with a PBS-Tween20 solution
extensively and then probed with species-specific secondary antibodies donkey anti-goat IR dye 800 and
donkey anti-mouse IR dye 700. Membranes were again washed extensively and blots were imaged on
Odyssey Infrared imager. The results were reproducible in at least two independent assays.
https://doi.org/10.1371/journal.pone.0184629.g002

The supernatant collected from infected wells in each group at day 4-post infection was
subjected to plaque assay for virus titer determination (Fig 4D). The viral titers from mutant
M protein decreased at least by 2–3 logs compared to wt or HRSV alone. The HRSV produces
its own matrix proteins and competes with the transfected mutant M protein and the reduction of viral titer may be due to mutant M protein incorporation into viral assembly and budding. The virus stuck on the cell membrane may not have been released into the media
supernatant and this may account for reduction of viral titers in the mutant cell group. In
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Fig 3. RSV matrix sequence alignment. ClustalW sequence alignment of Matrix protein comparing human
RSV with various animal respiratory syncytial virus strains. The available sequences are aligned via ClustalW
with color coding to indicate conservation (Black = identical, pink = strong similarity, green = weak similarity,
white = no similarity). The conserved YXXL among human RSV is shown in a box.
https://doi.org/10.1371/journal.pone.0184629.g003

order to get significant reduction of viral titers and the effect of virus infection, a recombinant
HRSV with mutation of M in the viral genome is required which we plan to conduct future
experiments with experts in the generation of recombinant HRSV.

AP3Mu3A is specifically up-regulated late in HRSV infection
One of the interesting qualitative observations noticed throughout CLSM analysis was during
late infection; there seemed to be a significant difference in the amount of AP3Mu3A seen in
infected cells versus uninfected cells. To understand this, HEp2 cells were either infected or
mock-infected and cell lysates were extracted at 6 and 24 hour post infection time points to be
analyzed by Western Blot (Fig 5A). Equivalent amounts of cell lysate were loaded and after
subsequent transfer of SDS-PAGE gels to nitrocellulose followed by probing with primary and
secondary antibodies, as described in methods section; fluorescent intensities were collected
on Licor Imager. Statistical analysis showed that at 6 hours there was no statistical difference
between the amount of AP3Mu3A in infected versus uninfected cells (p-value = 0.5032), while
at 24 hours post infection there existed a statistically significant, greater than two fold, increase
in the amount of AP3Mu3A in infected cells versus uninfected cells (p-value = .0094) (Fig 5A).
To determine if the whole AP-3 adaptor complex was up-regulated, the delta-adaptin subunit
was also analyzed via the same protocol as the MU subunit just described. The results of this
analysis showed that there was no statistically significant difference between infected and uninfected cells at 6 (p-value = 0.4415), and 24-hour post infection (p-value = .2635) (Fig 5B). This
data seems to suggest that the AP-3 MU subunit is preferentially up-regulated during HRSV
infection, possibly due to the requirement of the AP3Mu3A subunit for proper function of the
RSV M protein during HRSV infection.
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Fig 4. Effect of mutation in YXXL domain of HRSV M protein. A) Sequence alignment of Matrix protein
amino acids 197–200 comparing various animal respiratory syncytial virus strains. The black regions highlight
the conserved tyrosine and the Tyr+4 hydrophobic amino acid residue (leucine) at residues 197 and 200
respectively. [Human HRSV Long Strain (HHRSV Long), HHRSV Strain A,B (HHRSV A,B), Bovine HRSV
(BHRSV), Ovine HRSV (OHRSV), Pneumonia Virus of Mice (PVM), Avian Metapneumovirus Strain A,B,C
(APV A/B/C), Human Metapneumovirus Strain A (HMPV A)]. B) Schematic diagram of the Opt.M and pointmutated Opt.M constructs. The diagram highlights the proposed adaptor protein (AP) basolateral sorting motif
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(shown in single letter amino acid code), the putative nuclear export signal (NES) (8) and the nuclear
localization signal within amino acids 110–183, the binding site for Importin beta1 (10). Single letter code
values refer to the beginning of the M amino acid sequence. Bold letters indicate the putative 197-YXXL-200
and possible di-leucine sequence motif located in M from amino acids 200–202. C) The mutation of the
tyrosine at amino acid residue 197 to alanine and leucine at amino acid residue 200 to alanine causes a
distinct phenotypic change in the localization of the HRSV Matrix protein. HEp2 cells were transfected with
indicated pEGFP-C1 Opt. M constructs and were fixed with paraformaldehyde at 24 hours post transfection
as described previously. Cells were imaged for Opt.M, adaptor protein and DAPI using CLSM protocols
described previously. Negative controls include transfection of cells with empty plasmid vector (pEGFP-C1)
without M insert (left side panel) and mock transfected cells with staining for adaptor protein only with goat anti
Ap3u3A followed by rabbit anti goat Alexa Fluor 546 antibody (right side panel). The first 3 images on the left
side panel shows staining for Opt.M and DAPI. The first 3 images on the right side panel shows merged image
with staining for Opt.M, adaptor protein and DAPI. The results were reproducible in at least two independent
assays. D) Mutation in YXXL domain of M reduces HRSV titer. The HEp-2 cells were transfected with control
plasmid, WT-M, Y197A or L200A mutant plasmids and infected with HRSV. Four days after infection,
supernatants were collected, and the virus titer was measured by plaque assay. Representative data from
three independent experiments are shown. The results were reproducible in at least two independent assays.
https://doi.org/10.1371/journal.pone.0184629.g004

Discussion
In this study, we show the elucidation of a novel interaction between the AP-3 complex and
the HRSV M protein specifically through the AP-3Mu3A subunit, which plays a role in trafficking. This interaction was initially found via a yeast-two hybrid system and then further
confirmed in mammalian models by colocalization and co-immunoprecipitation studies.
Sequence alignment performed using Clustal W comparing the various RSV matrix proteins
show that a highly conserved homologous binding motif, YXXL was present, providing further
evidence that an interaction with the adaptor protein Mu subunits is critical for RSV to maintain function in pathogenesis across various RSV strains. The presence of a conserved tyrosine
based sorting signal motif, 197-YXXL-200, across various RSV-related strains and the results
of point-mutated colocalization and co-immunoprecipitation studies indicate that AP-3Mu3A
mediated trafficking of M is contingent on the presence of the tyrosine and leucine residues at
amino acid residue 197 and 200, respectively in the 197-YXXL-200 sorting sequence of M. The
M protein in the point mutation constructs, Y-197-A and L200A Opt.M, were seen localized
exclusively in nuclear and juxtanuclear regions especially absent in cytoplasmic regions
extending to the cell margin (Fig 4C). The HRSV may be seen budding but appear stuck and
unable to get released from the cell membrane. This observation suggests that because of the
mutation of these vital tyrosine and leucine residues, the ability of AP-3 to direct M properly
away from the juxtanuclear region toward cytoplasmic inclusions and/or sites of viral assembly
late in infection was halted or impaired. The viral titers from mutant M protein decreased at
least by 2–3 logs compared to wt-M or HRSV alone (Fig 4D). One reason for only 2–3 logs
decrease in viral titer may be because the normal matrix protein produced by the virus may
compete with the transfected mutant M protein and the reduction of viral titer may be due to
mutant M protein incorporation into viral assembly and budding. The virus stuck on the cell
membrane may not have been released into the media supernatant and this may account for
reduction of viral titers in the mutant cell group. In order to get significant reduction of viral
titers and the effect of virus infection, a recombinant HRSV with mutation of M in the viral
genome is required which we plan to conduct future experiments with experts in the generation of recombinant HRSV.
Previous studies have elucidated various sites in the trafficking itinerary of the Matrix protein as it has been shown to exit the nucleus through a Crm-1 mediated nuclear export mechanism [7] and subsequently localize late in infection to cytoplasmic inclusions with the N, P and
M2-1 proteins [14], with G in the Golgi [22] and later with the F protein at the plasma
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Fig 5. AP3Mu3A is up-regulated at 24 hours post-infection in infected cells versus mock infected
HEp2 cells while at 6 hours there was no statistically significant difference. The AP3delta subunit was
also analyzed and it was determined that there was no statistical significant difference in infected cells versus
mock infected cells at both 6 and 24hours post-infection. 15μg of cell lysate, extracted by MPER (Pierce) were
analyzed by 4–12% Bis-Tris SDS-PAGE gels (Invitrogen) in triplicate and transferred to nitrocellulose. Blots
were blocked overnight in Rockland IR blocking buffer, then probed with the following antibodies diluted in
50% Tween-20 Wash Buffer: 50% Rockland blocking buffer for one hour incubation periods with extensive
wash periods between incubations: Primary antibodies used are Goat anti-Ap3m1 (1:200), Mouse anti-RSV
Matrix (1:1000), Rabbit anti-delta adaptin (SA4) (1:1000), Rabbit anti-GAPDH (1:10000), and secondary
antibody used are Donkey anti-Goat IR 800 (1:25000), Donkey anti-Rabbit IR 800 (1:25000), Donkey antiRabbit IR 700 (1:5000), Donkey anti-Mouse IR 700 (1:5000), Donkey anti-Mouse IR 800 (1:20000). Blots
were analyzed on Licor Imager and integral intensities were measured for each band corresponding to the
41kDa GAPDH, 47 kDa AP3Mu3A, and 160 kDa delta-adaptin bands. The statistical analysis was performed
on the ratio of the integral intensity measurement of the triplicate average of the protein of interest versus the
GAPDH control in infected cells versus mock-infected cells at various time points post RSV infection.
https://doi.org/10.1371/journal.pone.0184629.g005
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membrane in lipid rafts [5]. Recently the elucidation of a novel budding pathway by Crowe
et al demonstrated that HRSV uses a budding mechanism controlled by Rab11-FIP2, a major
apical recycling endosome (ARE) protein [23]. The ARE is located just below the apical membrane and is marked by the presence of Rab11a [24]. The ARE serves as a slow recycling endosome as well as the final destination for basolateral to apical membrane transcytosing proteins
[25].
This has major implications in the elucidation of the trafficking itineraries of HRSV viral
proteins as it has also been shown that the normal apical sorting signals, glycophosphatidylinositol (GPI) anchors, N-glycans, O-glycans, that are found only in the HRSV envelope glycoproteins (F, G and SH proteins), are not required for apical maturation or release of the virus. In
addition, the deletion of one or more of the glycoprotein genes had no affect on the recruitment of the remaining viral glycoproteins or the nucleocapsid protein to the apical membrane
[26]. Thus, a mechanism for the apical and basolateral trafficking of the M protein, a non-glycosylated inner virion protein, is crucial in understanding how HRSV proteins assemble at the
apical surface of polarized epithelial cells.
Further insights into how the interaction between HRSV M and AP-3 may be involved in
the assembly of HRSV particles late in infection stems from previous studies showing how the
AP-3 complex regulates the trafficking of exogenous viral proteins within endosomal and
trans-Golgi compartments. Studies have demonstrated the role of AP-3delta in directing the
intracellular trafficking of HIV-1 Gag and for efficient transport of Vesicular Stomatitis Virus
(VSV) G protein from the trans-Golgi network (TGN) to the cell-surface [27, 28, 29]. Furthermore, the di-leucine mediated interaction between the HIV-1 Nef protein and AP-1MU and
AP-3Mu stabilizes the association of the AP complexes with membranes that influences the
viral infectivity of HIV-1 through alteration of the early/recycling endosomal compartments
[16, 17, 27, 30].
Of note, in addition to the 197-YXXL-200 basolateral sorting signal at amino acids 197–200
of the M protein, there exists three consecutive encoded leucines at amino acid residues 200–
202 that could possibly make up two separate di-leucine motifs, another conserved sorting signal shown previously to regulate the interaction between adaptor protein complexes and exogenous viral proteins. Previously, in the investigation of the Crm-1 nuclear export mechanism
used by the HRSV Matrix protein, Ghildyal et al disrupted the putative C-terminal nuclear
export signal (cNES) at amino acids 194–206, by mutating a classic leucine rich motif. The
authors mutated all three leucine residues to alanine residues and it resulted in the inability of
the Matrix protein to export from the nucleus. Thus, it is difficult to assess whether or not the
di-leucine motif could also be implicated as a trafficking motif because the M protein is maintained within the nucleus [7]. Recent publication has shown that the Thr205 Phosphorylation
Site within matrix Protein Modulates M Oligomerization and Virus Production [31].
The observation that the AP-3Mu1 subunit is up-regulated at 24 hours post infection but
not at 6 hours is also further evidence that the interaction with the AP-3 complex may be
involved in viral assembly or budding. The finding that the AP-3delta subunit is not up-regulated indicates that there may be a requirement for the cells to either maintain AP-3Mu1 protein from degradation or is up-regulated at a transcriptional level.
Based on our results and information from published literature, we propose a model for
‘Trafficking route of HRSV M and AP-3 in epithelial cells’, as shown in Fig 6 which was
adapted with permission from Rodriguez-Boulan et al., 2005 [32]. HRSV M protein after exiting the trans-Golgi network (TGN) interacts with AP3 adaptor protein via YXXL domain and
reach common recycling endosomes (CREs) and apical recycling endosomes (AREs). The
ARE serves as a slow recycling endosome as well as the final destination for basolateral to apical membrane transcytosing proteins. A recent paper by Kipper et al., 2015 has shown that M
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Fig 6. Trafficking route of HRSV M and AP-3 in epithelial cells (adapted with permission from
Rodriguez-Boulan et al Nature Reviews 2005, 233–247). HRSV M protein after exiting the trans-Golgi
network (TGN) interacts with AP3 adaptor protein via YXXL domain and reach common recycling endosomes
(CREs) and apical recycling endosomes (AREs). The ARE serves as a slow recycling endosome as well as the
final destination for basolateral to apical membrane transcytosing proteins. M may also interact with Exocyst
Complex Component 6 (EXOC6), which is involved in vesicular trafficking from the Golgi to plasma membrane.
The M protein then interacts with the major ARE-associated protein, Rab11 family interacting protein 2 (FIP2)
and help in the budding of the virus through lipid rafts. Abbreviations: basal sorting endosomes (BSEs), late
endosomes (LEs) and lysosomes (LYS), apical sorting endosomes (ASEs), common recycling endosomes
(CREs), apical recycling endosomes (AREs), trans-Golgi network (TGN), Exocyst Complex Component 6
(EXOC6).
https://doi.org/10.1371/journal.pone.0184629.g006

interacts with Exocyst Complex Component 6 (EXOC6), which is involved in vesicular trafficking from the Golgi to plasma membrane [33]. The M protein may then interact with the
major ARE-associated protein, Rab11 family interacting protein 2 (FIP2) [23] and help in the
budding of the virus through lipid rafts.
The elucidation of the interaction between RSV M and AP-3 sheds light on one piece of a
complex pathway by which viral and cellular components interact to direct RSV viral particle
formation. Future research may unravel important details of the virus-host machinery that is
involved in Golgi and endosomal sorting, including the roles of lipid rafts, sorting signals,
adaptor proteins, and the microtubule- and actin-based cytoskeleton.
Although HRSV is a prime candidate for early childhood immunization and antiviral drug
therapy, at present, the only treatment available is a monoclonal antibody administered to
high-risk infants [34]. Thus, the results of this study add new insights and targets that may lead
to the development of potential antivirals and attenuating mutations suitable for candidate
vaccines in the future.
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Supporting information
S1 Fig. The HRSV M protein co-immunoprecipitates with the AP-3Mu3A complex during
HRSV infection. a1) The HRSV M protein co-immunoprecipitates with the AP-3Mu3A complex during HRSV infection. HEp2 cells at approximately 90% confluency were either infected
at an MOI of 5 or mock infected for 24 hours, cells were scraped or proteins were subsequently
extracted using MPER. Cell lysates were incubated for 6 hours with 1 μg of polyclonal goat
anti-AP-3Mu3A at 4˚C on a rotating device. 20μl Protein A/G agarose beads were added to
lysate plus corresponding antibody and incubated overnight. Immunoprecipate complex was
pelleted and washed with PBS and then ran out on a SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was blocked and then probed with monoclonal mouse antiMatrix primary antibody as described previously for one hour. Membranes were then washed
with a PBS-Tween20 solution extensively and then probed with species-specific secondary
antibodies donkey anti-mouse IR dye 700. Membranes were again washed extensively and
blots were imaged on Odyssey Infrared imager. The last lane shows protein molecular weight
marker (KDa). The results were reproducible in at least two independent assays. a2) The
HRSV M protein co-immunoprecipitates with the AP-3Mu3A complex during HRSV infection. HEp2 cells at approximately 90% confluency were either infected at an MOI of 5 or mock
infected for 24 hours, cells were scraped or proteins were subsequently extracted using MPER.
Cell lysates were incubated for 6 hours with 1 μg of polyclonal goat anti-AP-3Mu3A at 4˚C on
a rotating device. 20μl Protein A/G agarose beads were added to lysate plus corresponding
antibody and incubated overnight. Immunoprecipate complex was pelleted and washed with
PBS and then ran out on a SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was blocked and then probed with polyclonal goat-anti HRSV primary antibody as
described previously for one hour. Membranes were then washed with a PBS-Tween20 solution extensively and then probed with species-specific secondary antibodies donkey anti-goat
IR dye 800. Membranes were again washed extensively and blots were imaged on Odyssey
Infrared imager. The last lane shows protein molecular weight marker (KDa). The results were
reproducible in at least two independent assays. b1) The HRSV M protein co-immunoprecipitates with the AP-3delta complex during HRSV infection. HEp2 cells at approximately 90%
confluency were either infected at an MOI of 5 or mock infected for 24 hours, cells were
scraped or proteins were subsequently extracted using MPER. Cell lysates were incubated for 6
hours with 1 μg of monoclonal mouse anti-AP-3delta at 4˚C on a rotating device. 20μl Protein
A/G agarose beads were added to lysate plus corresponding antibody and incubated overnight.
Immunoprecipate complex was pelleted and washed with PBS and then ran out on a
SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was blocked and then
probed with monoclonal mouse anti-Matrix primary antibody as described previously for one
hour. Membranes were then washed with a PBS-Tween20 solution extensively and then
probed with species-specific secondary antibodies donkey anti-mouse IR dye 700. Membranes
were again washed extensively and blots were imaged on Odyssey Infrared imager. The last
lane shows protein molecular weight marker (KDa). The results were reproducible in at least
two independent assays. b2) The HRSV M protein co-immunoprecipitates with the AP-3delta
complex during HRSV infection. HEp2 cells at approximately 90% confluency were either
infected at an MOI of 5 or mock infected for 24 hours, cells were scraped or proteins were subsequently extracted using MPER. Cell lysates were incubated for 6 hours with 1 μg of monoclonal mouse anti-AP-3delta at 4˚C on a rotating device. 20μl Protein A/G agarose beads were
added to lysate plus corresponding antibody and incubated overnight. Immunoprecipate complex was pelleted and washed with PBS and then ran out on a SDS-PAGE gel and transferred
to nitrocellulose membrane. Membrane was blocked and then probed with polyclonal goat-

PLOS ONE | https://doi.org/10.1371/journal.pone.0184629 October 13, 2017

16 / 20

Human Respiratory Syncytial Virus matrix protein interacts with cellular adaptor protein complex 3

anti HRSV primary antibody as described previously for one hour. Membranes were then
washed with a PBS-Tween20 solution extensively and then probed with species-specific secondary antibodies donkey anti-goat IR dye 800. Membranes were again washed extensively
and blots were imaged on Odyssey Infrared imager. The last lane shows protein molecular
weight marker (KDa). The results were reproducible in at least two independent assays. c)
Representative. The HRSV M protein co-immunoprecipitates with the AP-3Mu3A (lanes
1–3) and AP-3delta (lanes 7–9) complex during HRSV infection. HEp2 cells at approximately
90% confluency were either infected at an MOI of 5 (lanes 1–3 and 7–9) or mock infected
(lanes 4–6 and 10–12) for 24 hours, cells were scraped or proteins were subsequently extracted
using MPER. Cell lysates were incubated for 6 hours with 1 μg of either polyclonal goat antiAP-3Mu3A (lanes 1–6) or monoclonal mouse anti-AP-3delta (lanes 7–12) at 4˚C on a rotating
device. 20μl Protein A/G agarose beads were added to lysate plus corresponding antibody and
incubated overnight. Immunoprecipate complex was pelleted and washed with PBS and then
ran out on a SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was
blocked and then probed with polyclonal goat-anti HRSV primary antibody as described previously for one hour. Membranes were then washed with a PBS-Tween20 solution extensively
and then probed with species-specific secondary antibodies donkey anti-goat IR dye 800.
Membranes were again washed extensively and blots were imaged on Odyssey Infrared
imager. The samples were run in triplicates. Lane 13 shows protein molecular weight marker
(KDa). The results were reproducible in at least two independent assays. d) Representative
negative control. HEp2 cells at approximately 90% confluency were either infected at an MOI
of 5 (lanes 1–3 and 7–9) or mock infected (lanes 4–6 and 10–12) for 24 hours, cells were
scraped or proteins were subsequently extracted using MPER. Cell lysates were incubated for 6
hours with 1 μg of either polyclonal goat anti-H1N1antibodies (lanes 1–6) or monoclonal
mouse anti-HIV-1 p24 Gag antibodies (lanes 7–12) at 4˚C on a rotating device. 20μl Protein
A/G agarose beads were added to lysate plus corresponding antibody and incubated overnight.
Immunoprecipate complex was pelleted and washed with PBS and then ran out on a
SDS-PAGE gel and transferred to nitrocellulose membrane. Membrane was blocked and then
probed with polyclonal goat-anti HRSV primary antibody as described previously for one
hour. Membranes were then washed with a PBS-Tween20 solution extensively and then
probed with species-specific secondary antibodies donkey anti-goat IR dye 800. Membranes
were again washed extensively and blots were imaged on Odyssey Infrared imager. The samples were run in triplicates. Lane 13 shows protein molecular weight marker (KDa). The results
were reproducible in at least two independent assays.
(TIF)
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